Mount Yale Investment Advisors, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2018$40,000
-16.7%
16,0000.0%0.01%
-22.2%
Q2 2018$48,00016,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$49,697,00012.67%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 9,642,760$31,628,0005.74%
MILLER VALUE PARTNERS, LLC 12,619,730$41,393,0001.84%
MAGNOLIA CAPITAL ADVISORS LLC 90,585$297,0000.38%
Sargent Investment Group, LLC 232,025$759,0000.28%
Old West Investment Management, LLC 210,583$690,0000.20%
Virtus ETF Advisers LLC 112,619$369,0000.18%
tru Independence LLC 213,712$701,0000.10%
Golden State Wealth Management, LLC 90,585$297,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 180,297$591,0000.08%
View complete list of ZIOPHARM ONCOLOGY INC shareholders